Tracking Cell Fate With Noninvasive Imaging

Journal of the American College of Cardiology

Volumn 54, Issue 17, 2009, Pages 1627-1628

  Feigenbaum, Gary S ^a   Lemberg, Louis ^a   Hare, Joshua M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

adenosine; cardiac stem cells; fibrin glue; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BRADYCARDIA; CELL FATE; CELL LABELING; CELL THERAPY; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HEART ARREST; HEART DISEASE; HEART INFARCTION; IMAGING SYSTEM; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEM CELL;

ANIMALS; CELL SURVIVAL; HEART; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RATS; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 70349835372     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.05.067     Document Type: Editorial

References (22)

1. Segers V.F., and Lee R.T. Stem-cell therapy for cardiac disease. Nature 451 (2008) 937-942
2. Mosterd A., and Hoes A.W. Clinical epidemiology of heart failure. Heart 93 (2007) 1137-1146
3. Boyle A.J., Schulman S.P., Hare J.M., and Oettgen P. Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair. Ready for the next step. Circulation 114 (2006) 339-352
4. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102 (2005) 11474-11479
5. Martin-Rendon E., Brunskill S.J., Hyde C.J., Stanworth S.J., Mathur A., and Watt S.M. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 29 (2008) 1807-1818
6. Terrovitis J., Lautamäki R., Bonios M., et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 54 (2009) 1619-1626
7. Smith R.R., Barile L., Cho H.C., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115 (2007) 896-908
8. Hofmann M., Wollert K.C., Meyer G.P., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111 (2005) 2198-2202
9. Tousoulis D., Briasoulis A., Antoniades C., Stefanadi E., and Stefanadis C. Heart regeneration: what cells to use and how?. Curr Opin Pharmacol 8 (2008) 211-218
10. Thielmann M., Massoudy P., Marggraf G., et al. Impact of intraoperative myocardial cellular damage on early hemodynamics after off-pump versus on-pump coronary artery bypass surgery. Eur J Med Res 10 (2005) 218-226
11. Hamamoto H., Gorman III J.H., Ryan L.P., et al. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann Thorac Surg 87 (2009) 794-801
12. Lipinski M.J., Biondi-Zoccai G.G., Abbate A., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50 (2007) 1761-1767
13. Amado L.C., Schuleri K.H., Saliaris A.P., et al. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol 48 (2006) 2116-2124
14. Zhang Y., Ruel M., Beanlands R.S., deKemp R.A., Suuronen E.J., and DaSilva J.N. Tracking stem cell therapy in the myocardium: applications of positron emission tomography. Curr Pharm Des 14 (2008) 3835-3853
15. Chapon C., Jackson J.S., Aboagye E.O., Herlihy A.H., Jones W.A., and Bhakoo K.K. An in vivo mu5ltimodal imaging study using MRI and PET of stem cell transplantation after myocardial infarction in rats. Mol Imaging Biol 11 (2009) 31-38
16. Rad A.M., Arbab A.S., Iskander A.S., Jiang Q., and Soltanian-Zadeh H. Quantification of superparamagnetic iron oxide (SPIO)-labeled cells using MRI. J Magn Reson Imaging 26 (2007) 366-374
17. Kraitchman D.L., Heldman A.W., Atalar E., et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107 (2003) 2290-2293
18. Doyle B., Kemp B.J., Chareonthaitawee P., et al. Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J Nucl Med 48 (2007) 1708-1714
19. Metz S., Bonaterra G., Rudelius M., Settles M., Rummeny E.J., and Daldrup-Link H.E. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 14 (2004) 1851-1858
20. Jin Y., Kong H., Stodilka R.Z., et al. Determining the minimum number of detectable cardiac-transplanted 111In-tropolone-labelled bone-marrow-derived mesenchymal stem cells by SPECT. Phys Med Biol 50 (2005) 4445-4455
21. Ponomarev V., Doubrovin M., Shavrin A., et al. A human-derived reporter gene for noninvasive imaging in humans: mitochondrial thymidine kinase type 2. J Nucl Med 48 (2007) 819-826
22. Narsinh K.H., Cao F., and Wu J.C. Molecular imaging of human embryonic stem cells. Methods Mol Biol 515 (2009) 13-32